Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam to prevent emergence agitation after pediatric laparoscopic hernia surgery
ChiCTR2000038840Phase 4Completed
- Sponsor
- The Affiliated Hospital of Guangdong Medical University
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of remimazolam in Emergence agitation (EA) (2 arms), sponsored by The Affiliated Hospital of Guangdong Medical University. Primary endpoint: Emergence agitation score (PAED scale). Started Nov 2021; status: completed.
02
Drugs
remimazolam
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on ChiCTR2000038840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038840.